Amedisys Inc.
AMED.US | Other human health activities
Amedisys, Inc. is a leading provider of home health, hospice, and high-acuity care services in the United States. The company delivers personalized healthcare to patients in their homes, focusing on improving their quality of life and overall health outcomes. Amedisys' services include skilled nursi...Show More
Better Health for All
0
Amedisys' core services, including home health, hospice, and palliative care, are dedicated to improving patient quality of life and health outcomes.
1
The company's home health services have a CMS 4.33-star rating, with 33% of its centers achieving 4.5 stars or higher, exceeding the national average of 29%.
2
All Amedisys care centers are Medicare and Medicaid certified, and its hospice services achieved 7 out of 7 on hospice item set scores.
3
The company's business model is entirely oriented toward health improvement, with no evidence of harmful products or activities.
4
For price accessibility, 100% of eligible patients are covered by Medicare, and Medicaid and private insurance are also accepted.
5
Amedisys offers specialty programs for conditions like COPD, heart failure, diabetes, dementia, and veterans.
6
The Amedisys Foundation provides financial assistance to employees facing unexpected emergencies and patients experiencing hardship.
7
The company adheres to HIPAA compliance for patient data privacy.
8
Amedisys mentions providing education for caregivers, including fall reduction programs.
9
The company established a Diversity, Equity, and Inclusion Council in 2020 and has several Employee Resource Groups.
10
Fair Money & Economic Opportunity
0
Amedisys Inc. is a healthcare provider, not a financial institution. The company's core business does not involve lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, profit reinvestment, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity, are not applicable. The provided articles confirm the absence of quantitative data relevant to these financial metrics, focusing instead on diversity, equity, and inclusion or a philanthropic foundation.
1
Fair Pay & Worker Respect
-20
The CEO to median employee pay ratio was 361:1 for the 2023 fiscal year.
1
The Total Recordable Incident Rate (TRIR) was 3.97 in 2021.
2
Employee satisfaction, as measured by quarterly employee engagement surveys in 2021, was 7% higher than the industry average, with an 83% participation rate.
3
The voluntary employee turnover rate was 20.4% in 2021, and a full-time turnover rate of 18% and overall rate of 22% was reported more recently, stated to be below the industry average.
4
The company has incurred multiple labor-law violations, including wage and hour violations totaling $8,837,757, with the most recent wage violation in 2021, and workplace safety or health violations totaling $17,067, with the most recent safety violation in 2024.
5
Fair Trade & Ethical Sourcing
0
Amedisys is a healthcare service provider and does not procure or trade physical commodities, making the 'fair_trade_cert_share' KPI not applicable.
1
No specific, quantitative evidence was provided for the remaining KPIs, including supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, the percentage of supplier contracts with enforceable ethical-sourcing clauses, spend on high-risk materials, or procurement budget directed to diverse suppliers.
2
Honest & Fair Business
0
The provided articles, primarily from Amedisys's investor relations and corporate compliance pages, outline the company's commitment to compliance, employee training, and ongoing monitoring.
1
However, they do not contain any specific quantitative data points or concrete details relevant to the requested KPIs for Honest & Fair Business, such as regulatory fines, transparency scores, whistleblower policy specifics, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict percentages, anti-corruption policy strength, or third-party verification of ethical claims.
2
Therefore, no KPIs can be scored based on the evidence provided.
Kind to Animals
0
Amedisys is a service-oriented company providing home health, hospice, and high-acuity care services. The provided articles do not contain evidence that the company manufactures products requiring cruelty-free certification, conducts animal testing, uses animal-derived ingredients, or engages in animal husbandry or agriculture. Therefore, all KPIs related to these activities are not applicable to the company's core business model and no specific, measurable data points were found to score them. While Amedisys operates a 'Trees in Memory' program, planting 104,782 trees by Q1 2025, the evidence states these trees 'benefit wildlife' but does not provide the measurable biodiversity impact or species recovery metrics required by the 'wildlife_conservation_impact' KPI rubric.
1
No War, No Weapons
-20
Amedisys, a healthcare services provider, has no defense or arms-related activities in its core business, nor does it engage in dual-use technology development with military applications.
1
The company is not involved in exports requiring end-user certificates, sales to embargoed regimes, or defense-related lobbying.
2
It is not subject to the Arms Trade Treaty and has no AI systems used militarily.
3
Amedisys joined the UN Global Compact in 2022, indicating support for UN Guiding Principles in principle.
4
The company has a Code of Ethical Business Conduct that applies to all directors, officers, and employees.
5
In 2021, 100% of employees received compliance training, demonstrating full compliance with ethical standards in core business operations.
6
Planet-Friendly Business
0
No evidence available to assess Amedisys Inc on Planet-Friendly Business.
Respect for Cultures & Communities
-10
Amedisys has no reported cultural appropriation incidents.
1
The company's business model does not appear to involve formal partnerships with indigenous or local community groups, nor does it impact cultural contexts requiring a cultural impact assessment protocol or Free, Prior and Informed Consent (FPIC) processes. There is no specific tracking of indigenous suppliers, local procurement share, or cultural preservation investment.
2
The company's charitable contributions were $250,000 in 2021,
3
which is less than 1% of its 2020 revenue of $2.071 billion,
4
placing it below the 1-3% threshold for local community development reinvestment. Amedisys's Patients’ Special Needs Fund provided nearly $600,000 in grants to patients in 2021,
5
and the Employees 1st Fund provided nearly $300,000 to team members in 2021,
6
but these are not explicitly defined as non-core revenue distributions to community development funds. Amedisys offers a 24/7 compliance hotline for employees to raise concerns,
7
but there is no evidence of grievance mechanisms available to community stakeholders.
8
A job description for an RN Home Health position states, "Must speak English in good, understandable terms,"
9
indicating limited local language incorporation. While all people leaders undertake 'Leading Inclusively' training and caregivers can access short courses on diversity and inclusion,
10
there is no percentage of employees completing cultural sensitivity training.
11
Safe & Smart Tech
-40
Amedisys received HITRUST certification for internally developed applications.
1
The company conducts annual cybersecurity management and incident training for all employees.
2
In 2015, a data breach affected 6,909 individuals due to 142 missing encrypted laptops and computers, representing 0.3% of devices, which were assigned to former employees who left between 2011 and 2014.
3
These devices had 256-bit encryption, but the company could not rule out unauthorized access.
4
This incident was a HIPAA violation for failure to recall devices and implied a lack of comprehensive risk analysis and effective risk management.
5
The company's website privacy policy states users can review, correct, update, or modify their information and opt out of certain communications.
6
It also states compliance with HIPAA, CMIA, GDPR, and CCPA.
7
Management provides an annual overview of cybersecurity threat risk management and strategy to the Audit Committee, and the Chief Information Security Officer and Chief Information Officer have over 30 years of experience in managing cybersecurity.
8
Zero Waste & Sustainable Products
0
No specific, quantitative evidence was found in the provided articles to assess Amedisys Inc. against any of the Key Performance Indicators for the 'Zero Waste & Sustainable Products' ethical value. pertains to a different company, Stericycle, Inc., and its hazardous waste management violations, thus it is not relevant to AMED.US.
1
, Amedisys' inaugural ESG report, explicitly states that no quantitative data related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education is provided in the excerpt.
2
The mention of a net-zero GHG emissions target by 2050 is a carbon reduction effort, which is explicitly excluded from this value's scope unless related to waste management, for which no connection is made.
3